Leadership
Mir Imran, Chairman and CEO
Mir Imran founded InCube Labs to focus on his passion: creating medical solutions that change the standard of care in critical healthcare markets. After attending medical school, Mir began his career as a healthcare entrepreneur in the late 1970's and has founded numerous game-changing companies since those early days. Over the decades, he has become one of the leading inventors and entrepreneurs in the field. Mir now holds more than 200 issued patents and is perhaps most well known for his pioneering contributions to the first FDA-approved Automatic Implantable Cardioverter Defibrillator. As an entrepreneur, Mir has founded more than 20 life sciences companies; 15 of his companies have seen "liquidity events" (IPO/Acquisition). Mir's expertise spans a wide range of clinical areas from interventional cardiology to chronic pain, obesity and CNS disorders. Mir actively collaborates with the nation's top universities on research and development including Stanford, Rutgers, Johns Hopkins, UTSW, etc. Mir also founded InCube Ventures, a life sciences venture fund, where he has led investments in a range of promising ventures. Mir sits on Boards of several life sciences companies. He holds an M.S. in bioengineering and a B.S. in electrical engineering from Rutgers. He also attended CMDNJ/Rutgers Medical School.
Mir Hashim, Vice President, Research & Development
Mir Hashim brings more than 20 years of pharmaceutical research and development experience to InCube Labs, including leadership and management of a multi-laboratory, multi-group, pharmacology section. His breadth of knowledge and experience in pharmacology and physiology spans a variety of therapeutic areas including CNS, cardiovascular, gastrointestinal, anesthesia, and metabolic diseases such as diabetes and obesity. Prior to InCube, Mir spent 18 years at Glaxo Smith Kline where he most recently served as the head of Pharmacology. Mir has deep experience in drug discovery and development, international regulatory submissions, international product development, as well as in-licensing and out-licensing of drug candidates. Mir holds a B.S. in Biology and Chemistry from Osmania University, India; an M.S. in Biology from Central University of Hyderabad, India, as well as a PhD in Medicine/Pharmacology from Memorial University, St. John's, Canada.
Stephanie McGrory, Vice President of Business Development
Stephanie brings more than 15 years of marketing, communications and business management experience. In her role at InCube, Stephanie is responsible for marketing and business development, as well as strategic alliances. Prior to joining InCube, Stephanie was a founding member and EVP of Greenough Communications, a national marketing services firm that served a range of industries from technology to life sciences. There she handled business development; strategy, execution and project management of major customer engagements; as well as agency operations. Stephanie holds a B.A. in English from The College of the Holy Cross.
Syed Zaidi, Vice President of Accounting & Administration
Syed is an industry veteran with more than 25 years of experience in management and accounting. He has been instrumental in launching and running operations for more than a dozen start-ups in the last 15 years, and currently manages day-to-day operations for InCube Labs including overseeing all accounting and HR functions. Syed received his MBA in General Accounting and Management from Osmania University in Hyderabad, India.
Sanjay Patel, Senior Director, Clinical Research
Sanjay's experience in the pharmaceutical industry spans 20 years in management and clinical research positions. He acquired strategic and project management experience in diverse sized pharmaceuticals companies encompassing a variety of therapeutic areas including anesthesia, diabetes mellitus (Types I & II), Alzheimer's disease, uterine fibroids, endometriosis, intractable pain, rheumatoid arthritis, multiple sclerosis, and Crohn's Disease. His extensive experience includes participation in clinical development teams that have led to FDA approval of agents for anesthesia, chronic intractable pain, and Crohn's disease. Sanjay has worked in small- to medium-sized public pharmaceutical companies (Neurocrine, Elan, Avera, and Cadence), as well as drug development consulting to small start-up companies such as Addrenex and MicroIslet. From 1990 to 2000, he served in clinical research positions
at Burroughs Wellcome Co and later at Glaxo Wellcome in Research Triangle Park, NC, where he led the clinical development for the company's lead drug molecule in anesthesia. Sanjay holds a Bachelor of Pharmacy degree and a PhD in medicinal chemistry, both from the University of Bath, UK.
Joel Harris, Senior Director of Intellectual Property
Joel brings more than 20 years of experience in the medical device industry including 12 years of IP experience developing and managing patent portfolios for emerging medical device companies. Joel has worked for Wilson Sonsini Goodrich & Rosati PC, Townsend and Townsend and Crew LLP and Rita Medical Systems Inc. Joel has also held engineering and management positions at divisions of Guidant, Abbott Laboratories and Johnson and Johnson. Joel is admitted to practice before the United States Patent and Trademark Office. He is a graduate of Santa Clara Law School and a recipient of an Emery Scholarship for Academic Achievement and Witkin and Cali Awards for Academic Excellence (Golden Gate University). In addition to his law degree, Joel holds a B.S. Degree in Chemical Engineering from Northwestern University and an M.S. Degree in Bioengineering from Penn State University.
Dean Andersen, Director, Electrical Engineering
Dean brings more than 15 years experience in electrical engineering, with a specialty in ultra low power embedded systems, implantable circuit/system design and implantable RF system design. Prior to InCube, Dean was a senior principal engineer and manager of ASIC development at St. Jude Medical where he developed next generation chip set for pacemakers and ICDs. Dean also was a design engineer at Ventritex working on implantable ICDs. Dean received his M.S. in electrical engineering from Stanford and his B.S in electrical engineering from San Jose State.
Paren Shah, Director, Mechanical Engineering
Paren has 20 years experience in mechanical and biomedical engineering, with expertise in precision mechanism design, robotics, laser processing and MEMS. Prior to InCube, Paren held senior mechanical engineering positions at J&J Conor Medsystems, Adept Technology, Inc., Active Optical Networks, Spire Technologies and RSC Engineering. He led the development of Conor's drug eluting stent filling platform and volume manufacturing capabilities in the US and Ireland. In addition, Paren invented and has built several advanced laser processing platforms using Excimer, Femtosecond and YAG lasers. Paren holds patents on spatial light modulators and wafer probing mechanisms and has several pending applications. He has an M.S. in engineering from San Jose State University, with a specialty in microelectronics materials and biomedical devices, and a B.S. in mechanical engineering from the University of Poona in India.